PTC Therapeutics Inc PTCT

NAS: PTCT | ISIN: US69366J2006 24/10/2025

66,40 USD (-0,60%)

(-0,60%) 24/10/2025

Grafiek PTC Therapeutics Inc

Grafiek PTC Therapeutics Inc

1 dag1d -0,60%
1 week1w -2,87%
1 maand1m 12,56%
3 maanden3m 49,75%
6 maanden6m 33,44%
1 jaar1j 64,03%
5 jaar5j 27,82%

dinsdag 4 november 2025, 22:00

Kwartaalcijfers (3de kwartaal)

PTC Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

21 oktober 2025 · PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial Results · Persbericht

1 oktober 2025 · PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

21 augustus 2025 · PTC Therapeutics to Participate at Upcoming Investor Conferences · Persbericht

19 augustus 2025 · PTC Therapeutics Receives Complete Response Letter for Vatiquinone NDA · Persbericht

7 augustus 2025 · PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results · Persbericht

28 juli 2025 · PTC Therapeutics Announces FDA Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) · Persbericht

21 juli 2025 · PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2025 Financial Results · Persbericht

24 juni 2025 · PTCT Investors Have Opportunity to Join PTC Therapeutics, Inc. Fraud Investigation with the Schall Law Firm · Persbericht

23 juni 2025 · Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU) · Persbericht

19 juni 2025 · PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

Profiel PTC Therapeutics Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.ptcbio.com

Hoofdzetel: South Plainfield, New Jersey Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe